Trending News

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Popular

AI Analyst Top Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

Sareum Holdings PLC (GB:SAR)

LSE:SAR

SAR

Sareum Holdings

RESEARCH TOOLSreports

Sareum Holdings (SAR) Price & Analysis

Compare

26 Followers

SAR Stock Chart & Stats

12.00p

0.10p(0.44%)

At close: Jan 09 4:00 PM EST

12.00p

0.10p(0.44%)

Day’s Range― - ―

52-Week Range9.50p - 29.00p

Previous CloseN/A

Volume41.80K

Average Volume (3M)619.72K

Market Cap

£20.71M

Enterprise Value26.44M

Total Cash (Recent Filing)£4.14M

Total Debt (Recent Filing)£0.00

Price to Earnings (P/E)―

Beta-0.75

Next Earnings

Mar 26, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.02

Shares Outstanding138,065,170

10 Day Avg. Volume1,134,615

30 Day Avg. Volume619,716

Financial Highlights & Ratios

PEG Ratio0.00

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Sareum Holdings News

Sareum Holdings Passes All Resolutions at AGM, Strengthening Governance

Sareum Holdings ( ($GB:SAR) ) has shared an announcement. Sareum Holdings plc announced that all resolutions at its...

2d ago

Sareum Holdings Advances Pipeline and Strengthens Portfolio

Sareum Holdings ( ($GB:SAR) ) has shared an update. Sareum Holdings has made significant progress in its pipeline,...

3d ago

Sareum Holdings Announces AGM and Releases Annual Report

Sareum Holdings ( ($GB:SAR) ) has provided an update. Sareum Holdings PLC has announced its Annual General Meeting...

25d ago

Sareum Holdings Enhances Financial Advisory Team with New Joint Broker Appointment

The latest announcement is out from Sareum Holdings ( ($GB:SAR) ). Sareum Holdings PLC has appointed Singer Capital...

1M ago

Sareum Holdings Reports Progress in Drug Development and Strategic Collaborations

Sareum Holdings ( ($GB:SAR) ) has issued an announcement. Sareum Holdings PLC announced its unaudited financial results for...

2M ago

Sareum Holdings Discontinues Toxicology Study for SDC-1801 Amid Safety Concerns

Sareum Holdings ( ($GB:SAR) ) has issued an announcement. Sareum Holdings has discontinued its 16-week GLP preclinical toxicology...

2M ago

Sareum Holdings to Announce Financial Results and Host Investor Presentation

Sareum Holdings ( ($GB:SAR) ) has issued an announcement. Sareum Holdings PLC announced it will release its financial...

2M ago

Sareum Holdings Raises Funds Through Warrant Exercise

Sareum Holdings ( ($GB:SAR) ) just unveiled an announcement. Sareum Holdings announced the exercise of warrants for 20,200...

3M ago

Sareum Holdings Increases Share Capital Through Warrant Exercise

Sareum Holdings ( ($GB:SAR) ) just unveiled an announcement. Sareum Holdings plc announced the exercise of warrants to...

3M ago

Sareum Holdings Expands Share Capital Through Warrant Exercise

Sareum Holdings ( ($GB:SAR) ) has issued an update. Sareum Holdings plc has announced the exercise of warrants...

4M ago

SAR FAQ

What was Sareum Holdings PLC’s price range in the past 12 months?

Sareum Holdings PLC lowest share price was 9.50p and its highest was 29.00p in the past 12 months.

What is Sareum Holdings PLC’s market cap?

Sareum Holdings PLC’s market cap is £20.71M.

When is Sareum Holdings PLC’s upcoming earnings report date?

Sareum Holdings PLC’s upcoming earnings report date is Mar 26, 2026 which is in 105 days.

How were Sareum Holdings PLC’s earnings last quarter?

Sareum Holdings PLC released its earnings results on Oct 23, 2025. The company reported -0.024p earnings per share for the quarter, missing the consensus estimate of N/A by -0.024p.

Is Sareum Holdings PLC overvalued?

According to Wall Street analysts Sareum Holdings PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Sareum Holdings PLC pay dividends?

Sareum Holdings PLC does not currently pay dividends.

What is Sareum Holdings PLC’s EPS estimate?

Sareum Holdings PLC’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Sareum Holdings PLC have?

Sareum Holdings PLC has 138,065,170 shares outstanding.

What happened to Sareum Holdings PLC’s price movement after its last earnings report?

Sareum Holdings PLC reported an EPS of -0.024p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 17.857%.

Which hedge fund is a major shareholder of Sareum Holdings PLC?

Currently, no hedge funds are holding shares in GB:SAR

Company Description

Sareum Holdings PLC

Sareum Holdings (SAR) is a UK-based biotechnology company focused on drug discovery and development, particularly in the area of kinase inhibitors for cancer and autoimmune diseases. The company leverages its expertise in structure-based drug design to identify and develop innovative small molecule therapeutics aimed at unmet medical needs.